Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12023386 Composition for treatment of Crigler-Najjar syndrome

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

December 28, 2021

Date of Patent

July 2, 2024

Patent Application Number

17563633

Patent Citations

‌

US Patent 7125717 Metabolically activated recombinant viral vectors and methods for their preparation and use

‌

US Patent 7172893 Virus vectors and methods of making and administering the same

‌

US Patent 7201898 Methods and compounds for controlled release of recombinant parvovirus vectors

‌

US Patent 7229823 Methods for increasing the efficiency of recombinant AAV product

‌

US Patent 7282199 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

‌

US Patent 7439065 Helper virus-free AAV production

‌

US Patent 7456683 Amplitude error compensating device and quadrature skew error compensating device

‌

US Patent 7588772 AAV capsid library and AAV capsid proteins

‌

US Patent 7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor

‌

US Patent 7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

•••

Patent Inventor Names

James M. Wilson

Jenny Agnes Sidrane

Anna P. Tretiakova

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

12023386

Patent Primary Examiner

CPC Code

Find more entities like US Patent 12023386 Composition for treatment of Crigler-Najjar syndrome

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.